Multicentre SMS Study - FR

NCT06640764 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2024-10-15

No results posted yet for this study

Summary

Prospective, multicentre, non controled, non randomised, clinical study to assess the performance and the stability of SMS femoral stem

Conditions

  • Dysplasia of Hip Joint
  • Hip Osteoarthritis
  • Traumatic Arthritis of Hip
  • Avascular Necrosis of Femur Head

Interventions

PROCEDURE

Total Hip Arthroplasty

Total Hip Arthroplasty with SMS Femoral Stem (Medacta)

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2034-09-01
Completion
2037-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640764 on ClinicalTrials.gov